Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Chhatrala

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Carcinogenesis|April 17, 2014
Targeted therapy in gastrointestinal malignanciesRavi Chhatrala, Yasmin Thanavala, Renuka Iyer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2014
Pseudomembranes do not always indicate Clostridium difficile infectionRavi Chhatrala, Samarth Patel, Woon Chow
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|September 20, 2011
Protein intake compliance of morbidly obese patients undergoing bariatric surgery and its effect on weight loss and biochemical parametersIoannis Raftopoulos, Bruce Bernstein, Kristine O'Hara, et al.
Oncology|July 18, 2013
Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trialRenuka Iyer, Ravi Chhatrala, Tracey Shefter, et al.
Cancer Chemotherapy and Pharmacology|July 14, 2017
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agentChristos Fountzilas, Ravi Chhatrala, Nikhil Khushalani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 13, 2015
Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markersRavi Chhatrala, M Bilal Siddiqui, R Todd Stravitz, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2015
De novo hepatic steatosis drives atherogenic risk in liver transplantation recipientsMichael O Idowu, Ravi Chhatrala, M Bilal Siddiqui, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Carcinogenesis|April 17, 2014
Targeted therapy in gastrointestinal malignanciesRavi Chhatrala, Yasmin Thanavala, Renuka Iyer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2014
Pseudomembranes do not always indicate Clostridium difficile infectionRavi Chhatrala, Samarth Patel, Woon Chow
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|September 20, 2011
Protein intake compliance of morbidly obese patients undergoing bariatric surgery and its effect on weight loss and biochemical parametersIoannis Raftopoulos, Bruce Bernstein, Kristine O'Hara, et al.
Oncology|July 18, 2013
Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trialRenuka Iyer, Ravi Chhatrala, Tracey Shefter, et al.
Cancer Chemotherapy and Pharmacology|July 14, 2017
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agentChristos Fountzilas, Ravi Chhatrala, Nikhil Khushalani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 13, 2015
Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markersRavi Chhatrala, M Bilal Siddiqui, R Todd Stravitz, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2015
De novo hepatic steatosis drives atherogenic risk in liver transplantation recipientsMichael O Idowu, Ravi Chhatrala, M Bilal Siddiqui, et al.
Pageof 1